We will continue to monitor India-China disengagement process, says US

US-State-Dept.jpg

US State Department spokesperson Ned Price (Image Source: Twitter/Ned Price)

US State Department spokesperson Ned Price also talked about India and US cooperation for Covid-19 vaccines to strengthen the global response to the virus. 

The US State Department spokesperson Ned Price on Monday said that the United States continues to monitor the India-China disengagement process. The remarks came after India and China completed their disengagement process in one part of the border territory in Leh Ladakh. 

India and China reached a mutual agreement for disengagement of troops from the most controversial area of North and South Pangong Lake and that both countries will push for the resolution of their outstanding matters in an orderly manner to make sure that the border areas remain peaceful.

During a press briefing, Price said: “We are closely following reports of troop disengagement and we welcome the ongoing efforts to deescalate the situation. We will continue to monitor the situation closely as both sides work toward a peaceful resolution.”

Price also talked about India and US collaborations for Covid-19 vaccines. He stated that India and the United States have built on a successful partnership and the two countries are working together to strengthen the global response to Covid-19. 

“US and India recently welcomed an initiative to collaborate through an international center of excellence in research focused on infectious disease including Covid and we look forward to an overarching memorandum of understanding (MoU) to enhance health cooperation,” said Price 

Price added that the two nations are working on developing diagnostics therapeutics vaccines to battle the disease and to understand the significance of producing critical drugs during this period and making them accessible globally. He stated that India has a well-established pharmaceutical sector that plays a crucial role in manufacturing life-saving drugs. He said: “We are pleased that the US pharmaceutical industry has been coordinating with the Indian pharma industry since the beginning of the Covid-19 pandemic.”

Also Read: India, China ties at Crossroads: A big challenge for the entire world

Also Read: All quiet on eastern front as India, China work for complete disengagement at LAC

Also Read: India’s Minister of Commerce welcomes US businesses to manufacture in India

Also Read: India a red-hot investment opportunity for clean energy transition, says top US official

Also Read: India-US military and security ties stronger than ever, says Indian envoy

Also Read: US calls India an important partner in the Indo-Pacific region and welcomes its emergence as a leading global power

Leave a Reply

Your email address will not be published. Required fields are marked *

scroll to top